Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy
Silmitasertib (CX-4945) is Senhwa's first-in-class CK2 inhibitor, currently under clinical development across multiple cancer indications. To date, the compound has been administered to hundreds of ...
A collection of useless and fun Python programs (and implementations of the TI python libraries) in TI Nspire CX II calculators (version 6.0+ which is not compatible with Ndless) ...
The outlook for artificial intelligence in Latin America is promising, but the region still has low levels of training in this technology, says Google’s vice president for Spanish-speaking Latin ...
PORQUIS JUNCTION - People are asked to use caution and follow emergency personnel's directions in Porquis Junction. Around 1:15 p.m., South Porcupine OPP issued an advisory about an incident on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results